Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Fernando Ramos Lopez"'
Autor:
Pedro M. Folegatti, Kate Harrison, Lorena Preciado-Llanes, Fernando Ramos Lopez, Mustapha Bittaye, Young Chan Kim, Amy Flaxman, Duncan Bellamy, Rebecca Makinson, Jonathan Sheridan, Sasha R. Azar, Rafael Kroon Campos, Mark Tilley, Nguyen Tran, Daniel Jenkin, Ian Poulton, Alison Lawrie, Rachel Roberts, Eleanor Berrie, Shannan L. Rossi, Adrian Hill, Katie J. Ewer, Arturo Reyes-Sandoval
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Chikungunya virus (CHIKV) is a reemerging mosquito-borne virus that has caused outbreaks in various regions of the world. Here the authors present safety and immunogenicity data from a phase 1 trial with the simian adenovirus vectored vaccine ChAdOx1
Externí odkaz:
https://doaj.org/article/e71818edfedb43ec92d1c8c53528e12d
Autor:
Andrés Noé, Mehreen S. Datoo, Amy Flaxman, Mohammad Ali Husainy, Daniel Jenkin, Duncan Bellamy, Rebecca A. Makinson, Richard Morter, Fernando Ramos Lopez, Jonathan Sheridan, Dimitrios Voukantsis, Naveen Prasad, Adrian V. S. Hill, Katie J. Ewer, Alexandra J. Spencer
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Protection from liver-stage malaria requires high numbers of CD8+ T cells to find and kill Plasmodium-infected cells. A new malaria vaccine strategy, prime-target vaccination, involves sequential viral-vectored vaccination by intramuscular and intrav
Externí odkaz:
https://doaj.org/article/54935d5124fa4127948dd2701b4b673f
Autor:
Mohammad Bosaeed, MD, Hanan H Balkhy, ProfMD, Sultan Almaziad, MD, Haya A Aljami, BSc, Hind Alhatmi, MD, Hala Alanazi, BSN, Mashael Alahmadi, BSc, Ayah Jawhary, MD, Mohammed W Alenazi, BSc, Abdulrahman Almasoud, BSc, Rawan Alanazi, PharmD, Mustapha Bittaye, PhD, Jeremy Aboagye, MSc, Nahla Albaalharith, BSN, Sarah Batawi, MD, Pedro Folegatti, MSc, Fernando Ramos Lopez, MSc, Katie Ewer, PhD, Khalid Almoaikel, PhD, Majed Aljeraisy, PharmD, Adel Alothman, MD, Sarah C Gilbert, ProfPhD, Naif Khalaf Alharbi, PhD
Publikováno v:
The Lancet Microbe, Vol 3, Iss 1, Pp e11-e20 (2022)
Summary: Background: ChAdOx1-vectored vaccine candidates against several pathogens have been developed and tested in clinical trials and ChAdOx1 nCoV-19 has now been licensed for emergency use for COVID-19. We assessed the safety and immunogenicity o
Externí odkaz:
https://doaj.org/article/a4481f13a44743cf9b25ddef09acabf6
Autor:
Angela M. Minassian, Yrene Themistocleous, Sarah E. Silk, Jordan R. Barrett, Alison Kemp, Doris Quinkert, Carolyn M. Nielsen, Nick J. Edwards, Thomas A. Rawlinson, Fernando Ramos Lopez, Wanlapa Roobsoong, Katherine J.D. Ellis, Jee-Sun Cho, Eerik Aunin, Thomas D. Otto, Adam J. Reid, Florian A. Bach, Geneviève M.C. Labbé, Ian D. Poulton, Arianna Marini, Marija Zaric, Margaux Mulatier, Raquel Lopez Ramon, Megan Baker, Celia H. Mitton, Jason C. Sousa, Nattawan Rachaphaew, Chalermpon Kumpitak, Nongnuj Maneechai, Chayanut Suansomjit, Tianrat Piteekan, Mimi M. Hou, Baktash Khozoee, Kirsty McHugh, David J. Roberts, Alison M. Lawrie, Andrew M. Blagborough, Fay L. Nugent, Iona J. Taylor, Kimberly J. Johnson, Philip J. Spence, Jetsumon Sattabongkot, Sumi Biswas, Julian C. Rayner, Simon J. Draper
Publikováno v:
JCI Insight, Vol 6, Iss 23 (2021)
Controlled human malaria infection (CHMI) provides a highly informative means to investigate host-pathogen interactions and enable in vivo proof-of-concept efficacy testing of new drugs and vaccines. However, unlike Plasmodium falciparum, well-charac
Externí odkaz:
https://doaj.org/article/8f5efdb3fb3a46f088a6c09f41c0d102
Autor:
Pedro M. Folegatti, Amy Flaxman, Daniel Jenkin, Rebecca Makinson, Lucy Kingham-Page, Duncan Bellamy, Fernando Ramos Lopez, Jonathan Sheridan, Ian Poulton, Jeremy Aboagye, Nguyen Tran, Celia Mitton, Rachel Roberts, Alison M. Lawrie, Adrian V. S. Hill, Katie J. Ewer, Sarah Gilbert
Publikováno v:
Vaccines, Vol 9, Iss 3, p 262 (2021)
Heterologous prime-boost strategies are known to substantially increase immune responses in viral vectored vaccines. Here we report on safety and immunogenicity of the poxvirus Modified Vaccinia Ankara (MVA) vectored vaccine expressing four Mycobacte
Externí odkaz:
https://doaj.org/article/3e8281ba4494441aaae4e83953650bf7
Autor:
Solopova, Veronika, Gruszczynski, Adrian, Rostom, Eiad, Cremer, Fritz, Witte, Sascha, Zhang, Chengming, Plößl, Fernando Ramos López Lea, Hofmann, Florian, Romeike, Ralf, Gläser-Zikuda, Michaela, Benzmüller, Christoph, Landgraf, Tim
Written reflective practice is a regular exercise pre-service teachers perform during their higher education. Usually, their lecturers are expected to provide individual feedback, which can be a challenging task to perform on a regular basis. In this
Externí odkaz:
http://arxiv.org/abs/2307.07523
Autor:
Pedro M. Folegatti, Duncan Bellamy, Amy Flaxman, Catherine Mair, Chris Ellis, Raquel L. Ramon, Fernando Ramos Lopez, Celia Mitton, Megan Baker, Ian Poulton, Alison Lawrie, Rachel Roberts, Angela Minassian, Katie J. Ewer, Thomas G. Evans, Adrian V. S. Hill, Sarah C. Gilbert
Publikováno v:
Vaccines, Vol 7, Iss 1, p 33 (2019)
Seasonal influenza infections have a significant global impact leading to increased health and economic burden. The efficacy of currently available seasonal influenza vaccines targeting polymorphic surface antigens has historically been suboptimal. C
Externí odkaz:
https://doaj.org/article/677f7b5551f64e5584d56367eb881a4b
Autor:
Borimas Hanboonkunupakarn, Mavuto Mukaka, Podjanee Jittamala, Kittiyod Poovorawan, Pongphaya Pongsuwan, Lisa Stockdale, Samuel Provstgaard-Morys, Kesinee Chotivanich, Joel Tarning, Richard M. Hoglund, Natenapa Chimjinda, Katie Ewer, Fernando Ramos-Lopez, Nicholas P. J. Day, Arjen M. Dondorp, Adrian V. Hill, Nicholas J. White, Lorenz von Seidlein, Sasithon Pukrittayakamee
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-8 (2024)
Abstract In preparation for mass vaccinations with R21/Matrix-M™ combined with mass administrations of dihydroartemisinin, piperaquine, and a single low dose primaquine we assessed the tolerability, safety, and potential interactions of this combin
Externí odkaz:
https://doaj.org/article/4be06bd127144f78b5cc122df3526075
Autor:
Jo, Salkeld, Yrene, Themistocleous, Jordan R, Barrett, Celia H, Mitton, Thomas A, Rawlinson, Ruth O, Payne, Mimi M, Hou, Baktash, Khozoee, Nick J, Edwards, Carolyn M, Nielsen, Diana Muñoz, Sandoval, Florian A, Bach, Wiebke, Nahrendorf, Raquel Lopez, Ramon, Megan, Baker, Fernando, Ramos-Lopez, Pedro M, Folegatti, Doris, Quinkert, Katherine J, Ellis, Ian D, Poulton, Alison M, Lawrie, Jee-Sun, Cho, Fay L, Nugent, Philip J, Spence, Sarah E, Silk, Simon J, Draper, Angela M, Minassian
Publikováno v:
Frontiers in immunology. 13
In endemic settings it is known that natural malaria immunity is gradually acquired following repeated exposures. Here we sought to assess whether similar acquisition of blood-stage malaria immunity would occur following repeated parasite exposure by
Autor:
Mehreen S Datoo, Hamtandi Magloire Natama, Athanase Somé, Duncan Bellamy, Ousmane Traoré, Toussaint Rouamba, Marc Christian Tahita, N Félix André Ido, Prisca Yameogo, Daniel Valia, Aida Millogo, Florence Ouedraogo, Rachidatou Soma, Seydou Sawadogo, Faizatou Sorgho, Karim Derra, Eli Rouamba, Fernando Ramos-Lopez, Matthew Cairns, Samuel Provstgaard-Morys, Jeremy Aboagye, Alison Lawrie, Rachel Roberts, Innocent Valéa, Hermann Sorgho, Nicola Williams, Gregory Glenn, Louis Fries, Jenny Reimer, Katie J Ewer, Umesh Shaligram, Adrian V S Hill, Halidou Tinto
Publikováno v:
The Lancet. Infectious diseases. 22(12)
Malaria is a leading cause of morbidity and mortality worldwide. We previously reported the efficacy of the R21/Matrix-M malaria vaccine, which reached the WHO-specified goal of 75% or greater efficacy over 12 months in the target population of Afric